Location History:
- Great Shelford, GB (2000 - 2002)
- Cambridgeshire, GB (2006 - 2013)
- London, GB (2016)
- Cambridge, GB (2017 - 2022)
Company Filing History:
8 out of 8 
2 out of 12 
2 out of 9 
Years Active: 2000-2024
Title: The Innovations of Terence Kevin O'Brien
Introduction
Terence Kevin O'Brien, based in Cambridge, GB, is a prominent inventor renowned for his contributions to medical technology. With a portfolio that boasts 11 patents, O'Brien has focused on enhancing the accuracy and reliability of physiological data monitoring, particularly in cardiovascular care.
Latest Patents
Among his latest innovations is the "Haemodynamic Monitor with Improved Filtering." This device and method filters outliers from physiological values, effectively improving the data's reliability. The technique involves populating a window with 'n' physiological values taken sequentially, where 'n' is a positive integer. O'Brien's method assesses the variability of these values, determining when a threshold is met to identify the presence of outliers. This breakthrough is crucial in ensuring that healthcare professionals receive accurate and dependable physiological data for patient monitoring.
Career Highlights
Throughout his career, Terence Kevin O'Brien has worked with several companies that are leaders in medical technology. He has been associated with Lidco Group Plc and Monitoring Technology Corporation, both of which have played a pivotal role in the development of advanced monitoring systems. His innovative spirit is reflected in his patent work, driving enhancements in patient care technologies.
Collaborations
O'Brien has collaborated with notable professionals in the field, including Eric Mills and David Marston Band. Their collective expertise has contributed to the refinement of monitoring technologies that improve patient outcomes.
Conclusion
Terence Kevin O'Brien’s work exemplifies the intersection of innovation and healthcare. With his significant contributions to the field through various patents and collaborations, O'Brien continues to make strides toward enhancing the accuracy of physiological monitoring, ultimately benefiting patient care across medical institutions. His legacy is one of dedication to improving medical technology for the future.